Plasma minichromosome maintenance complex component 6 is a novel biomarker for hepatocellular carcinoma patients

Hepatology Research

Volumn 44, Issue 13, 2014, Pages 1347-1356

  Zheng, Tenghao ^a   Chen, Ming ^a   Han, Shuangyin ^a   Zhang, Lida ^a   Bai, Yangqiu ^a   Fang, Xinhui ^a   Ding, Song Ze ^a   Yang, Yuxiu ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Circulating nucleic acids; Enzyme linked immunosorbent assay; Hepatocellular carcinoma; Minichromosome maintenance complex component 6; Real time quantitative polymerase chain reaction

Indexed keywords

MESSENGER RNA; MINICHROMOSOME MAINTENANCE PROTEIN 6; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER STAGING; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL ELECTROPHORESIS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY;

EID: 84927577339     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12303     Document Type: Article

References (30)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45: 529-538.
4. Simard EP, Ward EM, Siegel R, Jemal A. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin 2012; 62: 118-128.
5. Okuda K. Hepatocellular carcinoma. J Hepatol 2000; 32 (1 Suppl): 225-237.
6. Benson AB, 3rd, Abrams TA, Ben-Josef E etal. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw 2009; 7: 350-391.
7. Gebo KA, Chander G, Jenckes MW etal. Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review. Hepatology 2002; 36 (5 Suppl 1): S84-92.
8. Farinati F, Marino D, De Giorgio M etal. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? Am J Gastroenterol 2006; 101: 524-532.
9. Sherman M. Surveillance for hepatocellular carcinoma. Semin Oncol 2001; 28: 450-459.
10. Vlassov VV, Laktionov PP, Rykova EY. Extracellular nucleic acids. Bioessays 2007; 29: 654-667.
11. Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011; 11: 426-437.
12. Kaiser J. Medicine. Keeping tabs on tumor DNA. Science 2010; 327 (5969): 1074.
13. Ogawa Y, Takahashi T, Masukata H. Association of fission yeast Orp1 and Mcm6 proteins with chromosomal replication origins. Mol Cell Biol 1999; 19: 7228-7236.
14. Davies RJ, Freeman A, Morris LS etal. Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool. Lancet 2002; 359 (9321): 1917-1919.
15. Ayaru L, Stoeber K, Webster GJ etal. Diagnosis of pancreaticobiliary malignancy by detection of minichromosome maintenance protein 5 in bile aspirates. Br J Cancer 2008; 98: 1548-1554.
16. Gauchotte G, Vigouroux C, Rech F etal. Expression of minichromosome maintenance MCM6 protein in meningiomas is strongly correlated with histologic grade and clinical outcome. Am J Surg Pathol 2012; 36: 283-291.
17. Zhou YM, Zhang XF, Cao L etal. MCM7 expression predicts post-operative prognosis for hepatocellular carcinoma. Liver Int 2012; 32: 1505-1509.
18. Bai Y-Q, Ding G-W, Yang Y-X. Expression of differential genes during hepatocarcinogenesis. Shi Jie Hua Ren Xiao Hua Za Zhi 2008; 16: 2537-2541.
19. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471-1474.
20. Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis 2010; 30: 61-74.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
22. Lindner K, Gregan J, Montgomery S, Kearsey SE. Essential role of MCM proteins in premeiotic DNA replication. Mol Biol Cell 2002; 13: 435-444.
23. Blow JJ, Hodgson B. Replication licensing - defining the proliferative state? Trends Cell Biol 2002; 12: 72-78.
24. Giaginis C, Vgenopoulou S, Vielh P, Theocharis S. MCM proteins as diagnostic and prognostic tumor markers in the clinical setting. Histol Histopathol 2010; 25: 351-370.
25. Bruemmer D, Yin F, Liu J etal. Expression of minichromosome maintenance proteins in vascular smooth muscle cells is ERK/MAPK dependent. Exp Cell Res 2003; 290: 28-37.
26. Min L, He B, Hui L. Mitogen-activated protein kinases in hepatocellular carcinoma development. Semin Cancer Biol 2011; 21: 10-20.
27. Schmidt CM, McKillop IH, Cahill PA, Sitzmann JV. Increased MAPK expression and activity in primary human hepatocellular carcinoma. Biochem Biophys Res Commun 1997; 236: 54-58.
28. Blaschke F, Leppanen O, Takata Y etal. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries. Circ Res 2004; 95 (12): e110-123.
29. Chuang CH, Yang D, Bai G, Freeland A, Pruitt SC, Schimenti JC. Post-transcriptional homeostasis and regulation of MCM2-7 in mammalian cells. Nucleic Acids Res 2012; 40: 4914-4924.
30. Gonzalez MA, Tachibana KE, Laskey RA, Coleman N. Control of DNA replication and its potential clinical exploitation. Nat Rev Cancer 2005; 5: 135-141.